ICON completes USD 143m-acquisition of Aptiv Solutions
08 May 2014
Irish ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has completed the previously announced acquisition of Aptiv Solutions, Reston (VA), USA, for a purchase price of USD 143.5 million. Aptiv Solutions is a recognised leader in the design and execution of adaptive clinical trials for pharmaceutical and biotech customers and has operations in 16 countries.
Schellenberg Wittmer's Corporate/M&A Team acted as Swiss legal counsel to the acquirer. The Schellenberg Wittmer team consisted of Lorenzo Olgiati
(overall lead, partner Corporate/M&A), Christian Meier
, Pascal Hubli
and Ueli Hengartner
Back to overview